- Home
- FENG vs ASBP Comparison
FENG vs ASBP Comparison
Compare FENG & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- ASBP
- Stock Information
- Founded
- FENG 1998
- ASBP 2021
- Country
- FENG China
- ASBP United States
- Employees
- FENG N/A
- ASBP N/A
- Industry
- FENG Broadcasting
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- FENG Industrials
- ASBP Health Care
- Exchange
- FENG Nasdaq
- ASBP Nasdaq
- Market Cap
- FENG 29.7M
- ASBP 26.6M
- IPO Year
- FENG 2011
- ASBP N/A
- Fundamental
- Price
- FENG $2.11
- ASBP $0.54
- Analyst Decision
- FENG
- ASBP
- Analyst Count
- FENG 0
- ASBP 0
- Target Price
- FENG N/A
- ASBP N/A
- AVG Volume (30 Days)
- FENG 6.0K
- ASBP 1.1M
- Earning Date
- FENG 05-12-2025
- ASBP 05-24-2025
- Dividend Yield
- FENG N/A
- ASBP N/A
- EPS Growth
- FENG N/A
- ASBP N/A
- EPS
- FENG N/A
- ASBP N/A
- Revenue
- FENG $96,408,461.00
- ASBP N/A
- Revenue This Year
- FENG N/A
- ASBP N/A
- Revenue Next Year
- FENG N/A
- ASBP N/A
- P/E Ratio
- FENG N/A
- ASBP N/A
- Revenue Growth
- FENG 1.69
- ASBP N/A
- 52 Week Low
- FENG $1.67
- ASBP $0.52
- 52 Week High
- FENG $4.15
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- FENG 42.12
- ASBP N/A
- Support Level
- FENG $2.10
- ASBP N/A
- Resistance Level
- FENG $2.33
- ASBP N/A
- Average True Range (ATR)
- FENG 0.10
- ASBP 0.00
- MACD
- FENG -0.01
- ASBP 0.00
- Stochastic Oscillator
- FENG 20.00
- ASBP 0.00
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.